pharma · distal renal tubular acidosis (dRTA)
Advicenne
Advicenne S.A.
Advicenne is a pharma organization headquartered in EU. Primary therapeutic focus areas include distal renal tubular acidosis (dRTA). NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s)
Paris, FR HQ
16 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Paris, FR
- Employees
- 16
- Programs
- 1
- Drugs
- 2
- Patents
- 0
B06CS
Phase 1 · other · distal renal tubular acidosis (dRTA)
B06CS for distal renal tubular acidosis (dRTA) is a Phase 1 program (other) at Advicenne S.A. with 1 ClinicalTrials.gov record(s).
Internal code B06CS
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Advicenne S.A.
- Phase
- Phase 1
- Modality
- other
- Indication
- distal renal tubular acidosis (dRTA)
- Status
- active
- Trials
- 1